A Mutant of Human Papillomavirus Type 16 E6 Deficient in Binding -Helix Partners Displays Reduced Oncogenic Potential in Vivo

Journal of Virology - United States
doi 10.1128/jvi.76.24.13039-13048.2002
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

NFX1-123 and Poly(A) Binding Proteins Synergistically Augment Activation of Telomerase in Human Papillomavirus Type 16 E6-Expressing Cells

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2007English

PDZRN3/LNX3 Is a Novel Target of Human Papillomavirus Type 16 (HPV-16) and HPV-18 E6

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2014English

Oligonucleotide Array Analysis of Telomerase Activation by the Human Papillomavirus Type 16 E6 Protein

Nature Genetics
Genetics
2001English

NFX1-123 Increases hTERT Expression and Telomerase Activity Posttranscriptionally in Human Papillomavirus Type 16 E6 Keratinocytes

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2009English

The Role of Human Papillomavirus Type 16 E6/E7 Oncoproteins in Cervical Epithelial-Mesenchymal Transition and Carcinogenesis

Oncology Letters
Cancer ResearchOncology
2011English

The ING4 Binding With P53 and Induced P53 Acetylation Were Attenuated by Human Papillomavirus 16 E6

PLoS ONE
Multidisciplinary
2013English

Human Papillomavirus (HPV) 16 E6 Seropositivity Is Elevated in Subjects With Oral HPV16 Infection

Cancer Epidemiology
Cancer ResearchEpidemiologyOncology
2016English

Oncogenic Comparison of Human Papillomavirus Type 58 E7 Variants

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2018English

Human Papillomavirus 16 E6 and E7 Synergistically Repress Innate Immune Gene Transcription

mSphere
MicrobiologyMolecular Biology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy